Neo Medical Proclaims EU MDR Portfolio Success
Swiss Company’s CEO Talks On The Strategic Importance Of MDR Commitment
After raising $68m series B funding in September, Neo Medical's announced on 2 December that its entire product portfolio has secured EU MDR approval. Co-CEO and founder Vincent Lefauconnier explained the rationale to Medtech Insight.
